Geographic atrophy is a subtype of advanced age-related macular degeneration (AMD). It causes blind spots in the center of vision and a permanent loss of visual sharpness. AMD progresses through ...

Age-related macular degeneration (AMD ... we haven’t had any therapeutics to target the root cause of geographic atrophy, an advanced form of dry AMD. Pegcetacoplan (Syfovre) is the first ...

In this CE activity, experts in the field will assess how advances in imaging and new therapies for the management of geographic atrophy secondary to age-related macular degeneration can be ...

The large economic burden from late-stage age-related macular degeneration on patients, caregivers, and healthcare systems is from direct and indirect medical expenses, including well-being and ...

In this CE activity, experts in the field will assess how advances in imaging and new therapies for the management of geographic atrophy secondary to age-related macular degeneration can be ...

The large economic burden from late-stage age-related macular degeneration on patients ... and demographic factors are associated with geographic atrophy growth rate and may guide the selection ...

Astellas has suffered another major setback with geographic atrophy (GA ... in the US since 2023 for GA secondary to age-related macular degeneration (AMD), a leading cause of blindness, given ...

Show more The treatment of Geographic Atrophy (GA) or late stage dry age-related macular degeneration as it's also known, is proving to be a pretty tough nut to crack. Hopes had been high that a ...

Pulsesight Therapeutics SAS has submitted a clinical trial authorization (CTA) to the French authority ANSM seeking to conduct a first-in-human phase I trial of PST-611 for dry age-related macular ...

for the every-other-month treatment of adult patients with geographic atrophy (GA) secondary to age-related macular degeneration (AMD) with an intact fovea and when central vision is threatened by ...